Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D5H2SZ
|
|||
| Drug Name |
ExpressGraft
|
|||
| Indication | Diabetic foot ulcer [ICD-11: BD54; ICD-9: 707] | Phase 1 | [1] | |
| Company |
Mallinckrodt
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04134143) An Open-Label, Prospective, Safety, and Tolerability Study of ExpressGraft- C9T1 Skin Tissue in the Treatment of Diabetic Foot Ulcers. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.